Compare BFLY & THQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BFLY | THQ |
|---|---|---|
| Founded | 2011 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Electronics | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 871.5M | 753.1M |
| IPO Year | N/A | N/A |
| Metric | BFLY | THQ |
|---|---|---|
| Price | $4.07 | $19.71 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | ★ 4.8M | 158.9K |
| Earning Date | 02-27-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.53% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $88,447,000.00 | N/A |
| Revenue This Year | $13.77 | N/A |
| Revenue Next Year | $16.00 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 16.04 | N/A |
| 52 Week Low | $1.32 | $15.29 |
| 52 Week High | $4.98 | $20.38 |
| Indicator | BFLY | THQ |
|---|---|---|
| Relative Strength Index (RSI) | 67.28 | 66.68 |
| Support Level | $3.67 | $19.52 |
| Resistance Level | $4.29 | $20.14 |
| Average True Range (ATR) | 0.22 | 0.29 |
| MACD | 0.01 | 0.04 |
| Stochastic Oscillator | 74.42 | 71.71 |
Butterfly Network Inc is a digital health business transforming care with handheld, whole-body ultrasound. Powered by its proprietary Ultrasound-on-Chip technology, its solution enables the acquisition of imaging information from an affordable, powerful device that fits in a healthcare professional's pocket with a combination of cloud-connected software and hardware technology that is easily accessed through a mobile application. The company enables the practical application of ultrasound information in the clinical workflow. Butterfly iQ+ is an ultrasound device that can perform whole-body imaging in a single handheld probe using semiconductor technology. With its small, handheld size, low cost, and simple user interface.
abrdn Healthcare Opportunities Fund is a non-diversified closed-end fund in the United States. The fund's investment objective is to seek current income and long-term capital appreciation through investments in U.S. and non-U.S. companies.